Metraipolis › archive › dc_bed52a67b0e2

Proteoglycans in Prostate Cancer Progression and Therapy Resistance — Europe PMC PMID:41470114

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41470114
DOI
10.3390/medicina61122112
License (as archived)
solo-consultazione
Archived
2026-11-08T05:04:00.830Z
SHA-256 of the archived text
909f629d09348662ce9ba44e9dcbb965db40d97c43fbb2068dfda662b8b14c2f
Stable URL of this page
https://metraipolis.com/documento/dc_bed52a67b0e2

How to cite

Proteoglycans in Prostate Cancer Progression and Therapy Resistance — Europe PMC PMID:41470114 — Europe PMC (en), https://europepmc.org/article/MED/41470114 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bed52a67b0e2 (Metraipolis archive dc_bed52a67b0e2, sha256 909f629d09348662ce9ba44e9dcbb965db40d97c43fbb2068dfda662b8b14c2f)
BibTeX
@misc{dcbed52a67b0e2,
  title = {Proteoglycans in Prostate Cancer Progression and Therapy Resistance — Europe PMC PMID:41470114},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41470114},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bed52a67b0e2; sha256 909f629d09348662ce9ba44e9dcbb965db40d97c43fbb2068dfda662b8b14c2f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41470114. Agents can read the archived copy with the MCP tool read_document.